BioMike, who joined as an Operating Partner 2018, was formerly CEO of Oxford Gene Technology (“OGT”) for 13 years, where he led the company’s transformation from a licensing-led business model to a highly successful genomic products business before its sale to Sysmex Corporation in 2017. Before joining OGT, Mike held a number of senior positions at GE Healthcare/Amersham Biosciences, including Executive Vice Presi ....
Education
Degrees
Start Free Trial
Access "Michael R. Evans" Work Experience (Current/Past), Board Seats, Joined Date, Contact Details - Emailid/Phone and Investments (If any) in one connected platform (AcquityData).